USPTO serial 76595520
ADENOBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 8, 2007
- Examiner
- PRICE, WANDA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ADENOBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
1118 BH AMSTERDAM SCHIPHOL, NL
1118 BH AMSTERDAM SCHIPHOL, NL
1181NC Amstelveen, NL
1181NC Amstelveen, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
IRA S. DORMAN
IRA S DORMAN LAW OFFICE OF IRA S DORMAN330 ROBERTS ST STE 200EAST HARTFORD, CT 06108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; venous disorders, namely, deep venous thrombosis; cerebral diseases, namely, stroke, neurodegenerative pathologies, Alzheimer's disease, Parkinson's disease, sleep pathologies, depression, anxiousness, psychotic disorders, epilepsy, migraine headaches; inflammatory diseases, namely, osteoarthritis, rheumatoid arthritis, alkylosing spondylitis, tendonitis, acute gout, inflammatory bowel diseases, prostates, dysmenorrhoea, post-traumatic oedema, fever, cancer, colorectal cancer, ovarian cancer, breast carcinoma, leukemia, prostate cancer, neuroblastoma, apoptosis processes, cancer cachexia syndrome; inhibiting tumor cell growth; for use as chemotherapy efficacy enhancers; immune diseases induced by virus, namely, herpes, herpes zoster and Aids; diabetes, cholesterol and lipid disorders; eye disease, retina ischemic, retina degeneration, glaucoma, and dry eye; sexual dysfunction, angiogenesis, inner ear disease, neuropathic pain, pain during anaesthesia, pulmonary diseases, cystic fibrosis, pulmonary hypertension, exocrine gland disease; antiseptic preparations; dietary food supplements; animal feed additive for use as a nutritional supplement; and dressings for wounds, burns and surgical use | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 8, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 6, 2007 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jan 29, 2007 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jan 29, 2007 | PAPER RECEIVED | — | |
| Aug 1, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 9, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2006 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 19, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 20, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 17, 2006 | ALIE | ASSIGNED TO LIE | — |
| Mar 11, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 17, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2006 | PAPER RECEIVED | — | |
| Feb 17, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Feb 16, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 1, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 30, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 1, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 27, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2005 | PAPER RECEIVED | — | |
| Jan 6, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 17, 2004 | NWAP | NEW APPLICATION ENTERED | — |